Skip to main content
Clinical Trials/JPRN-UMIN000041817
JPRN-UMIN000041817
Recruiting
未知

Concentration of vascular endothelial growth factor and medicine in serum and aqueous humor of patients with neovascular age-related macular degeneration before and after anti-VEGF therapy - Serum and ocular VEGF and medicine concentration with age-related macular degeneration

Department of Ophthalmology, Shiga University of Medical Science0 sites30 target enrollmentSeptember 17, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
age-related macular degeneration
Sponsor
Department of Ophthalmology, Shiga University of Medical Science
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 17, 2020
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Department of Ophthalmology, Shiga University of Medical Science

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients are judged to be inappropriate by doctors in charge. Patients who would like to withdraw their consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials